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Abstract
There is a high prevalence of hypertension in elderly. Patients with long duration
hypertension will suffer from vascular structure damage including brain vessel. Chronic
disturbance in brain vascularization will lead to cognitive decline. This research aimed
to assess the association between hypertension and cognitive decline in elderly. Sixty
male elderly (60-75 years old) from posyandu lansia in Surakarta were involved in
this research. They were divided into 2 groups, hypertensive and normotensive, each
group consisted of 30 subjects. Subjects with a history of head injury, intracranial
tumor, and cerebrovascular disease were excluded from this study. Hypertension
status was obtained from the medical record. Hypertension level was based on
Joint National Committee VII ( JNC VII). Cognitive function was assessed using the
Montreal Cognitive Assessment (MoCA-INA). The mean age was 65.73±4.07 years
old in the hypertensive group and 65.17±3.16 years old in normotensive group. There
were significant differences in total MoCA-INA scores between hypertensive and
normotensive (22±4.28 versus 24±5.56, p <0.01). Hypertension level had a negative
correlation with total MoCA-INA score (r = - 0.318, p <0.01). We conclude that cognitive
function in elderly with hypertension is lower than normotensive. Hypertension level
has a strong correlation with cognitive decline in elderly.
1. Introduction
Elderly is at risk for hypertension. The prevalence of hypertension is increasing with
aging [1]. The blood vessel elasticity will decline in elderly. The decrease of elastic
connective tissue and collagen deposit will lead to arterial stiffness [2]. Blood vessel
remodeling will happen such as vascular smooth muscle cell hypertrophy then decrease
the lumen diameter. These conditions will increase peripheral vascular resistance and
blood pressure in elderly [3].
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One of the target organs in a hypertensive patient is brain [1]. Hypertension makes
early atherosclerosis process in intracranial and extracranial blood vessel [4]. The struc-
ture of the blood-brain barrier (BBB) is the key in brain homeostasis [5]. A study in human
and animal model shows association between chronic hypertension and blood-brain
barrier impairment [6, 7]. The alteration of BBB structure occur in big, medium, and small
blood vessel [8]. The abnormality of structure and cerebrovascular function become
brain pathogenesis because perfusion decline, micro bleeding and tissue ischemia [9].
Hypertension is a risk factor of cognitive function impairment. Some cross-sectional
studies describe the association between hypertension and cognitive decline [10]. The
National Health and Nutrition Examination Survey (NHANES) study showed hyperten-
sion status in elderly of≥70 years old has a correlationwith global cognitive performance
[11].
In the other hand, there were some studies showed different results. A longitudinal
study explored both population with Systolic Blood Pressure (SBP) of ≥160 mmHg and
SBP of <100 mmHg has bad cognitive function [12]. A cross sectional study describes an
association between high blood pressure with better global cognitive function [13]. The
studies in hypertension and cognitive function showed different results. The aim of this




Sixty male elderly (age 60-75 years old) were included in this study. All participants were
members of Posyandu Lansia and speak bahasa Indonesia fluently. They were divided
into 2 groups: normotensive and hypertensive; each group had 30 participants. Informed
consents were signed by all of the participants. Patients with a history of head injury,
cranial tumor and cerebrovascular disease were excluded.
2.2. Data collection
History of the participant’s diseases was taken from the medical record and confirmed
with interview. The status and level of hypertension also were taken frommedical record.
Hypertension criteria were SBP ≥140 mm Hg or diastolic blood pressure (DBP) ≥ 90
mm Hg. Hypertension levels were grouped based on average blood pressure in the
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medical record and based on The Seventh Report of Joint National Committee ( JNC VII)
classification [14]. Cognitive function assessment has done with validated Montreal Cog-
nitive Assessment Indonesian version (MoCA-INA) [15]. MoCA-INA instrument consist of
30 test items including some cognitive domain such as memory, attention, orientation,
naming, delayed recall and visuospatial. This instrument has been validated for 55-
85 years old subject [16]. Compare to other instruments to assess cognitive function,
MoCA is superior [17]. Some studies used MoCA to assess cognitive function decline or
impairment [18, 19]. The differences MoCA-INA between normotensive and hypertensive
were analyzed using Mann Whitney Test. The correlation between hypertension level
and MoCA-INA score were analyzed using the Spearman correlation test.
3. Results and discussion
Table 1 describes basic characteristics of the participants based on normotensive and
hypertensive group. The average age in both groups was similar. The average age
in normotensive group was 65.167 ±3.62 years old and 65.73 ± 4.07 in hypertensive
group. The subjects in both groups were mostly 60-64 years old. The education level
of participants showed that primary education was the most frequent (43.3%) and col-
lege/university is the lowest (11.7%).
The global cognitive performance assessed usingMoCA-INA showed a significant dif-
ference between the normotensive and hypertensive group in elderly (Table 2). Hyper-
tension status was taken from blood pressure measurement monthly and written in the
medical record. This study results showed MoCA-Ina score has a negative correlation
with hypertension level based on JNC VII.
This study analyzes cognitive function decline with MoCA-Ina instrument. Based on
MoCA-Ina score, the hypertensive group has lower cognitive function compared to nor-
motensive group. This finding is consistent with other studies that the increased blood
pressure is correlated with cognitive function decline in elderly [12, 20]. A study showed
SBP increasing contributes to early cognitive function decline [21].
This study showed hypertensive level has a negative correlation with cognitive func-
tion. This finding is consistent with a community-based research result subjects with
SBP of ≥160 mmHg and DBP ≥ 90 mm Hg has lower verbal function [22]. A longitudinal
study reported subjects with SBP ≥160 mmHg has worse global cognitive performance
than subjects with SBP of <140 mm Hg [23]. Similar research showed increased blood
pressure by 10 mmHg above baseline has a correlation with cognitive function decline
in the next 20 years [24].
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Age (years), mean ± SD 65.167± 3.163 65.73 ± 4.07 65.45±3.62
Age group (years old), n (%)
60 – 64 16 (53.3) 14 (46.7) 30 (50)
65 – 69 11 (36.7) 11 (36.7) 22 36.7)
70 - 75 3 (10) 5 (16,6) 8 (13.3)
Education level, n (%)
Primary 14 (46.6) 12 (40) 26 (43.3)
Junior high school 4 (13.3) 5 (16.7) 9 (15)
High school 7 (23.4) 11 (36.6) 18 (30)
College/University 5 (16.7) 2 (6.7) 7 (11.7)
Table 2: MoCA-INA scores on hypertension status and hypertension level.






Normotensive 30 (50) 24 ± 5.56 <0.01 -
Hypertensive 30 (50) 22 ± 4.28
Level of hypertension
Normal 21 (35) 24.68 ± 5.7
Prehypertension 9 (15) 23.32 ± 5.4 < 0.01 -0.318
Stage I hypertension 13 (21.7) 22.61 ± 4.34
Stage II hypertension 17 (28.3) 21.39 ± 4.22
Hypertension causes cognitive function decline through cerebrovascular function
impairment [9]. The remodeling and brain blood vessel stiffness lead to decrease brain
blood flow at rest [25]. In patients with hypertension, the brain microvascular become
thinner so decrease compensation ability by collateral vessel [26]. A hypertensive
condition will activate auto-regulation to maintain brain blood flow at the stable level.
The auto-regulation will prevent brain circulation damage, but the other side can cause
brain ischemia when happened suddenly [27]. The other mechanism of cerebrovascular
impairment in hypertension is atherosclerosis [4]. Hypertension leads to decrease anti-
thrombotic and anti-atherogenic of the endothelial cell [28].
Perfusion impairment in the brain is the underlying of cognitive function decline [1].
The dominant cognitive domains affected by hypertension are memory and executive
function [29]. Executive function is a process involves some brain functions to decide
and problem solving [30]. The cognitive disturbance caused by hypertension related to
neurodegenerative such as dementia. A study showed high blood pressure can increase
the risk of dementia [31]. Although the evidence of hypertension affects cognitive domain
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still unclear, some studies report blood pressure controlling improve cognitive decline
risk in elderly [32, 33].
The limitation of this study is the small number subject involved. A bigger number of
subjects is needed to generalize the result for population condition. Wider age subjects
will give more information the effect of hypertension to cognitive function in various
ages. Another limitation of this study is some factors affecting cognitive decline, such as
diabetes mellitus, smoking, hypercholesterolemia and obesity are not analyzed
4. Conclusion
This study proves a significant different MoCA-INA score in normotensive and hyper-
tensive participants. This result show global cognitive function in hypertension group
is lower than normotensive. The significant correlation between hypertension level and
MoCA-INA scores shows that hypertension level has a correlation with cognitive decline
in elderly.
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